TheraVida is dedicated to the development of new therapies that improve the lives of patients, with fewer side effects, improved safety and efficacy and better compliance.
Using a unique and patent-protected combination drug technology, TheraVida is able to develop pharmaceutical products that have significantly better side effect and safety profiles when compared with predecessor therapies. This same technology also has the potential to provide greater efficacy to patients.
TheraVida is a clinical stage company, with lead combination drug products going into Phase III human studies for the treatment of overactive bladder and urinary incontinence and Phase II human studies for the treatment of hyperhidrosis.
For more information about TheraVida, please contact us at:
177 Bovet Rd., Suite 600
San Mateo, California, USA, 94402